<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39463652</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Metastatic Sarcomatoid Carcinoma of the Larynx: A Case Report.</ArticleTitle><Pagination><StartPage>e70331</StartPage><MedlinePgn>e70331</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70331</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.70331</ELocationID><Abstract><AbstractText>Laryngeal spindle cell carcinoma (SpCC) is a unique and very aggressive form of laryngeal cancer. This neoplasm, consisting of malignant epithelial and mesenchymal elements, presents major diagnostic challenges, and there is a lack of conventional therapeutic approaches due to its rarity. This report describes a case of a 53-year-old female who experienced persistent difficulty speaking and a dry cough after contracting coronavirus disease 2019 (COVID-19). Histological and immunohistochemical studies confirmed the diagnosis of sarcomatoid cancer. Initially, the patient received cisplatin and doxorubicin-based chemotherapy. However, the tumor's growth prompted a change in treatment to weekly paclitaxel. Despite initial signs of improvement, the patient experienced acute alveolar hemorrhage, and sudden and severe bleeding in the small air sacs of the lungs, which unfortunately led to her death while receiving treatment in the critical care unit. The diagnosis and treatment of laryngeal SpCC pose significant challenges due to its uncommon and aggressive nature, and there is still no consensus on the most effective therapeutic approach. Existing therapies often incorporate modifications from other sarcoma regimes. Recent studies have demonstrated a possible positive reaction to immunotherapy, although further research is necessary to validate this. This report highlights the significant challenges of treating laryngeal sarcomatoid carcinomas and the importance of continued research to improve diagnostic and treatment options, especially given the absence of established guidelines.</AbstractText><CopyrightInformation>Copyright © 2024, Derfoufi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Derfoufi</LastName><ForeName>Jihane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Oujda, MAR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezzoug</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Medical Oncology, Mohammed VI University Hospital, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Oujda, MAR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Jarroudi</LastName><ForeName>Ouissam</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Medical Oncology, Mohammed VI University Hospital, Oujda, MAR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brahmi</LastName><ForeName>Sami Aziz</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Medical Oncology, Mohammed VI University Hospital, Oujda, MAR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afqir</LastName><ForeName>Said</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Oncology, Mohammed VI University Hospital, Oujda, MAR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cancer metastasis</Keyword><Keyword MajorTopicYN="N">female patient</Keyword><Keyword MajorTopicYN="N">oncological management</Keyword><Keyword MajorTopicYN="N">rare malignancy</Keyword><Keyword MajorTopicYN="N">sarcomatoid carcinoma of head-neck region</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39463652</ArticleId><ArticleId IdType="pmc">PMC11512813</ArticleId><ArticleId IdType="doi">10.7759/cureus.70331</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>A case report of spindle cell (sarcomatoid) carcinoma of the larynx. Boamah H, Ballard B. Case Rep Med. 2012;2012:370204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539458</ArticleId><ArticleId IdType="pubmed">23319954</ArticleId></ArticleIdList></Reference><Reference><Citation>Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space. Gale N, Poljak M, Zidar N. Head Neck Pathol. 2017;11:23–32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5340729</ArticleId><ArticleId IdType="pubmed">28247231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarcomatoid larynx carcinoma differential clinical evolution, on field statistical considerations. Ricciardiello F, Bocchetti M, Pellini R, et al. Am J Otolaryngol. 2021;42:102934.</Citation><ArticleIdList><ArticleId IdType="pubmed">33526270</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinosarcomas of the larynx: systematic review of the literature of a rare nosologic entity. Colizza A, Gilardi A, Greco A, et al. Eur Arch Otorhinolaryngol. 2022;279:1167–1173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8897376</ArticleId><ArticleId IdType="pubmed">34351467</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarcomatoid carcinoma of the larynx: report of a case (Article in French)  [
Aug;
2024 
];Chbani L, Belghiti H, Znati K. https://link.springer.com/article/10.1007/s10269-010-1970-z Oncologie. 2024 12:109–112.</Citation></Reference><Reference><Citation>A spindle cell carcinoma presenting with osseous metaplasia in the gingiva: a case report with immunohistochemical analysis. Katase N, Tamamura R, Gunduz M, et al. Head Face Med. 2008;4:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2627831</ArticleId><ArticleId IdType="pubmed">19040765</ArticleId></ArticleIdList></Reference><Reference><Citation>Head and neck cancers.  [
Aug;
2024 
]. 2021. https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet</Citation></Reference><Reference><Citation>Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases. Thompson LD, Wieneke JA, Miettinen M, Heffner DK. Am J Surg Pathol. 2002;26:153–170.</Citation><ArticleIdList><ArticleId IdType="pubmed">11812937</ArticleId></ArticleIdList></Reference><Reference><Citation>Spindle cell carcinoma of the larynx: a confusing diagnosis for the pathologist and clinician. Bostanci A, Ozbilim G, Turhan M. Case Rep Otolaryngol. 2015;2015:831835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4693008</ArticleId><ArticleId IdType="pubmed">26788392</ArticleId></ArticleIdList></Reference><Reference><Citation>Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ. Am J Otolaryngol. 1994;15:250–257.</Citation><ArticleIdList><ArticleId IdType="pubmed">7978023</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcinosarcoma de novo of the parotid gland. Staffieri C, Marioni G, Ferraro SM, Marino F, Staffieri A. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:0–40.</Citation><ArticleIdList><ArticleId IdType="pubmed">17630097</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. Forastiere AA, Zhang Q, Weber RS, et al. J Clin Oncol. 2013;31:845–852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3577950</ArticleId><ArticleId IdType="pubmed">23182993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sintilimab combined with anlotinib as first-line treatment for advanced sarcomatoid carcinoma of head and neck: a case report and literature review. Wang L, Huang Y, Sun X. Front Oncol. 2024;14:1362160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11080619</ArticleId><ArticleId IdType="pubmed">38725630</ArticleId></ArticleIdList></Reference><Reference><Citation>Efficacy of immune checkpoint inhibitors in lung sarcomatoid carcinoma. Domblides C, Leroy K, Monnet I, et al. J Thorac Oncol. 2020;15:860–866.</Citation><ArticleIdList><ArticleId IdType="pubmed">31991225</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>